Clinical trial
Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
NCT00319020 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00319020 |
|---|---|
| Title | Bosentan in Children With Pulmonary Arterial Hypertension Extension Study |
| Official title | An Open Label, Long-term, Safety, and Tolerability Extension Study Using the Pediatric Formulation of Bosentan in the Treatment of Children With Idiopathic or Familial Pulmonary Arterial Hypertension Who Completed FUTURE 1 |
| Acronym | FUTURE 2 |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Drug |
| Interventions | Bosentan |
| Enrollment | 33 |
| Start date | Aug 23, 2005 |
| Primary completion | Oct 28, 2011 |
| Completion | Oct 28, 2011 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 4, 2025 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: